Principal Consultant Katie Herrick shared an in-depth look at one of the most critical—and often overlooked—phases of a product's lifecycle: transitioning away from launch-phase affordability programs. This webinar explored post product launch in biopharma strategies for transitioning away from launch-phase affordability programs while maintaining long-term market access goals.

During the early stages of a launch, programs like QuickStart, Bridge, and Copay Vouchers are essential tools for overcoming limited payer coverage and driving early patient adherence. But as market access expands, manufacturers face a new and complex challenge—how to strategically phase out these introductory measures without disrupting patient care or undermining long-term access goals.

In this webinar, we moved beyond the why of implementation and focus on the how of sustainable transition, and offered actionable strategies for navigating this pivotal shift.

Key Takeaways:

The Launch Phase — Effective utilization of free trial and bridge programs during a pharma product launch to secure early adherence and build patient momentum..

The Transition — Identifying the key trigger points that signal when it's time to shift away from launch-focused patient assistance.

Best Practices — Proven approaches to minimize patient disruption while moving toward a sustainable, long-term access model.

• Tuesday, June 16th
• 1:00 PM EST